Bo Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bo Lv has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Chunbo Chen
Department of Critical Care Medicine, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), China
4 shared publications - Heng Ye
Department of Critical Care Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China
3 shared publications - Linhui Hu
Department of Critical Care Medicine, Maoming People’s Hospital, Maoming, China
3 shared publications Mengyuan Chen
3 shared publications- Ruibin Chi
Department of Critical Care Medicine, Xiaolan People's Hospital of Zhongshan, Zhongshan, Guangdong, China
3 shared publications Wenfeng Zhan
3 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8678-8689
COVID-19 vaccine hesitancy among the vaccinated: a cross-sectional survey
Background: Coronavirus disease 2019 (COVID-19) vaccines play a crucial role in preventing serious complications, including intensive care unit (ICU) and hospital admissions, and in reducing the symptoms associated with the infection. However, vaccine hesitancy has been identified as a significant barrier to COVID-19 vaccination. This survey aimed to investigate vaccine hesitancy by exploring and identifying the enablers and barriers to receiving the second dose of the COVID-19 vaccine in a small cohort who had already received a first dose of the COVID-19 vaccine. Methods: A cross-sectional survey was conducted with 959 individuals who received a second dose of the COVID-19 vaccine at Guangdong Provincial People’s Hospital, from February 18 to February 23, 2021. The survey investigated the socio-demographic characteristics of the participants, and the enablers and barriers to the COVID-19 vaccination. Results: In total, 959 individuals completed the survey. The participants had an average age of 43.23±9.86 years, and 80.0% were male, 84.8% were married, and 34.9% had additional private commercial insurance. In terms of vaccine complications, 11.5% reported mild allergic reactions, and 8.7% reported hypertension. Among the participants, 74.7% agreed to receive a second dose of the COVID-19 vaccine. A multivariate logistic regression analysis of the participants who received the first dose of the vaccine revealed a higher level of vaccine acceptance among males [odds ratio (OR) =0.58; P=0.005], older individuals (OR =0.97; P=0.001), those who were married (OR =0.57; P=0.007), those with additional private commercial insurance (OR =0.65; P=0.02), and those who had many colleagues and friends who had received the vaccine (OR =0.58; P=0.007). Conversely, those who misunderstood the safety profile and side effects of the vaccine (OR =4.34; PConclusions: COVID-19 vaccine hesitancy was lower among males, older individuals, those who were married, those with additional private commercial insurance, and those who had a number of supportive colleagues and friends who had received the vaccine. Misunderstandings of the safety profile of the vaccine and the related adverse events were associated with a higher rate of vaccine hesitancy. Education efforts should seek to reduce vaccine hesitancy by improving understandings of the safety profile and adverse events related to the COVID-19 vaccine, emphasizing the benefit-to-risk ratio both at the individual level and from a socioeconomic perspective. Reducing vaccine hesitancy will increase the uptake of the COVID-19 vaccine, which in turn will reduce morbidity, mortality, and hospitalization, including ICU and critical care admission, thus decreasing the social and economic burden.
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8678-8689
Open AccessCOVID-19 vaccine hesitancy among the vaccinated: a cross-sectional survey
Background: Coronavirus disease 2019 (COVID-19) vaccines play a crucial role in preventing serious complications, including intensive care unit (ICU) and hospital admissions, and in reducing the symptoms associated with the infection. However, vaccine hesitancy has been identified as a significant barrier to COVID-19 vaccination. This survey aimed to investigate vaccine hesitancy by exploring and identifying the enablers and barriers to receiving the second dose of the COVID-19 vaccine in a small cohort who had already received a first dose of the COVID-19 vaccine. Methods: A cross-sectional survey was conducted with 959 individuals who received a second dose of the COVID-19 vaccine at Guangdong Provincial People’s Hospital, from February 18 to February 23, 2021. The survey investigated the socio-demographic characteristics of the participants, and the enablers and barriers to the COVID-19 vaccination. Results: In total, 959 individuals completed the survey. The participants had an average age of 43.23±9.86 years, and 80.0% were male, 84.8% were married, and 34.9% had additional private commercial insurance. In terms of vaccine complications, 11.5% reported mild allergic reactions, and 8.7% reported hypertension. Among the participants, 74.7% agreed to receive a second dose of the COVID-19 vaccine. A multivariate logistic regression analysis of the participants who received the first dose of the vaccine revealed a higher level of vaccine acceptance among males [odds ratio (OR) =0.58; P=0.005], older individuals (OR =0.97; P=0.001), those who were married (OR =0.57; P=0.007), those with additional private commercial insurance (OR =0.65; P=0.02), and those who had many colleagues and friends who had received the vaccine (OR =0.58; P=0.007). Conversely, those who misunderstood the safety profile and side effects of the vaccine (OR =4.34; PConclusions: COVID-19 vaccine hesitancy was lower among males, older individuals, those who were married, those with additional private commercial insurance, and those who had a number of supportive colleagues and friends who had received the vaccine. Misunderstandings of the safety profile of the vaccine and the related adverse events were associated with a higher rate of vaccine hesitancy. Education efforts should seek to reduce vaccine hesitancy by improving understandings of the safety profile and adverse events related to the COVID-19 vaccine, emphasizing the benefit-to-risk ratio both at the individual level and from a socioeconomic perspective. Reducing vaccine hesitancy will increase the uptake of the COVID-19 vaccine, which in turn will reduce morbidity, mortality, and hospitalization, including ICU and critical care admission, thus decreasing the social and economic burden.
- Open Access
- 1 June 2025
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 16, 981-991
Reflecting on the Implementation of United Kingdom (UK) General Practitioner Training Models in China: Highlights From a Train-the-Trainer Pilot Program
Purpose: The rising number of Chinese general practitioners is placing pressure on the Chinese Health Care system to ensure the quality of training for competent general practitioners (GPs) to meet the significantly increased clinical service demand. To achieve the internationally recognized training standard, this project is collaborating with the most advanced general practitioner training system in UK, which has excellent track record of innovative research for co-designing train-the-trainer program. This program aims to reflect on the effective implementation of innovative training models in the context of Chinese GPs training system, ultimately aiming to improve the trainers’ capability in training the future Chinese general practitioners. Methods: This study was a cross-sectional survey with an online questionnaire seeking feedback from the GP teachers and trainers who attended the train-the-trainer program featuring co-designed online and offline teaching. Results: All participants were general practitioners; average age 42.5± 5.41 years, including 65% female, 65% consultant general practitioners, 60% general practitioners with PhD, average years of clinical practice being 17.7± 6.96, average years of teaching being 6.0± 1.41, average hours of teaching weekly being 2.1± 0.85, and average number of residents trained being 39.6± 51.87. “Webex project (online teaching)” received 70% approval among the participants as “Smart eLearning project (self-online learning and testing)” received 80%. The comparison analysis in demographic and baseline teaching experience between the teacher-dominated group and the student-dominated group found that there were no significant differences in age, gender, professional title, academic qualifications, years of employment, teaching experience, average weekly teaching hours, and the number of residents trained (P> 0.05). There was significant reduction in the use of “traditional theoretical teaching” after the training (P< 0.005). Conclusion: The train-the-trainer pilot program has achieved significant outcomes. The changing of teaching philosophy from adult learning perspectives has been highlighted with the progression from a trainer-centered model to a trainee-centered model for training competent general practitioners.
- 1 June 2025
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 16, 981-991
Open AccessReflecting on the Implementation of United Kingdom (UK) General Practitioner Training Models in China: Highlights From a Train-the-Trainer Pilot Program
Purpose: The rising number of Chinese general practitioners is placing pressure on the Chinese Health Care system to ensure the quality of training for competent general practitioners (GPs) to meet the significantly increased clinical service demand. To achieve the internationally recognized training standard, this project is collaborating with the most advanced general practitioner training system in UK, which has excellent track record of innovative research for co-designing train-the-trainer program. This program aims to reflect on the effective implementation of innovative training models in the context of Chinese GPs training system, ultimately aiming to improve the trainers’ capability in training the future Chinese general practitioners. Methods: This study was a cross-sectional survey with an online questionnaire seeking feedback from the GP teachers and trainers who attended the train-the-trainer program featuring co-designed online and offline teaching. Results: All participants were general practitioners; average age 42.5± 5.41 years, including 65% female, 65% consultant general practitioners, 60% general practitioners with PhD, average years of clinical practice being 17.7± 6.96, average years of teaching being 6.0± 1.41, average hours of teaching weekly being 2.1± 0.85, and average number of residents trained being 39.6± 51.87. “Webex project (online teaching)” received 70% approval among the participants as “Smart eLearning project (self-online learning and testing)” received 80%. The comparison analysis in demographic and baseline teaching experience between the teacher-dominated group and the student-dominated group found that there were no significant differences in age, gender, professional title, academic qualifications, years of employment, teaching experience, average weekly teaching hours, and the number of residents trained (P> 0.05). There was significant reduction in the use of “traditional theoretical teaching” after the training (P< 0.005). Conclusion: The train-the-trainer pilot program has achieved significant outcomes. The changing of teaching philosophy from adult learning perspectives has been highlighted with the progression from a trainer-centered model to a trainee-centered model for training competent general practitioners.
- Open Access
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1395833
MiR-122 overexpression alleviates oxygen–glucose deprivation-induced neuronal injury by targeting sPLA2-IIA
Background: Ischemic stroke (IS) is a neurological disease with significant disability and mortality. MicroRNAs were proven to be associated with cerebral ischemia. Previous studies have demonstrated miR-122 downregulation in both animal models of IS and the blood of IS patients. Nonetheless, the role and mechanism of miR-122-5p in IS remain unclear.Methods: We established primary human and mouse astrocytes, along with HT22 mouse hippocampal neuronal cells, through oxygen–glucose deprivation/reoxygenation (OGD/R) treatment. To assess the impact of miR-122, we employed CCK8 assays, flow cytometry, RT-qPCR, western blotting, and ELISA to evaluate cell viability, apoptosis, reactive oxygen species (ROS) generation, and cytokine expression. A dual-luciferase reporter gene assay was employed to investigate the interaction between miR-122 and sPLA2-IIA.Results: Overexpression of miR-122 resulted in decreased apoptosis, reduced cleaved caspase-3 expression, and increased cell viability in astrocytes and HT22 cells subjected to OGD/R. RT-qPCR and ELISA analyses demonstrated a decrease in mRNA and cytokine levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in both astrocytes and HT22 cells following miR-122 overexpression. Moreover, miR-122 overexpression reversed OGD/R-induced ROS levels and 8-OHdG formation in astrocytes. Additionally, miR-122 overexpression decreased the mRNA and protein expression of inducible nitric oxide synthase (iNOS). Furthermore, we found that miR-122 attaches to the 3′-UTR of sPLA2-IIA, thereby downregulate its expression.Conclusion: Our study demonstrates that miR-122-mediated inhibition of sPLA2-IIA attenuates OGD/R-induced neuronal injury by suppressing apoptosis, alleviating post-ischemic inflammation, and reducing ROS production. Thus, the miR-122/sPLA2-IIA axis may represent a promising target for IS treatment.
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1395833
Open AccessMiR-122 overexpression alleviates oxygen–glucose deprivation-induced neuronal injury by targeting sPLA2-IIA
Background: Ischemic stroke (IS) is a neurological disease with significant disability and mortality. MicroRNAs were proven to be associated with cerebral ischemia. Previous studies have demonstrated miR-122 downregulation in both animal models of IS and the blood of IS patients. Nonetheless, the role and mechanism of miR-122-5p in IS remain unclear.Methods: We established primary human and mouse astrocytes, along with HT22 mouse hippocampal neuronal cells, through oxygen–glucose deprivation/reoxygenation (OGD/R) treatment. To assess the impact of miR-122, we employed CCK8 assays, flow cytometry, RT-qPCR, western blotting, and ELISA to evaluate cell viability, apoptosis, reactive oxygen species (ROS) generation, and cytokine expression. A dual-luciferase reporter gene assay was employed to investigate the interaction between miR-122 and sPLA2-IIA.Results: Overexpression of miR-122 resulted in decreased apoptosis, reduced cleaved caspase-3 expression, and increased cell viability in astrocytes and HT22 cells subjected to OGD/R. RT-qPCR and ELISA analyses demonstrated a decrease in mRNA and cytokine levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in both astrocytes and HT22 cells following miR-122 overexpression. Moreover, miR-122 overexpression reversed OGD/R-induced ROS levels and 8-OHdG formation in astrocytes. Additionally, miR-122 overexpression decreased the mRNA and protein expression of inducible nitric oxide synthase (iNOS). Furthermore, we found that miR-122 attaches to the 3′-UTR of sPLA2-IIA, thereby downregulate its expression.Conclusion: Our study demonstrates that miR-122-mediated inhibition of sPLA2-IIA attenuates OGD/R-induced neuronal injury by suppressing apoptosis, alleviating post-ischemic inflammation, and reducing ROS production. Thus, the miR-122/sPLA2-IIA axis may represent a promising target for IS treatment.
- Open Access
- 27 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
The protective effect of social support on all-cause and cardio-cerebrovascular mortality among middle-aged and older adults in the US
The relationship between social support and mortality, especially cardio-cerebrovascular mortality, still has some limitations in the assessment of social support, sample selection bias, and short follow-up time. We used the data from 2005 to 2008 National Health and Nutrition Examination Survey to examine this relationship. The study analyzed a total of 6776 participants, divided into Group 1, Group 2, and Group 3 according to the social support score (0–1; 2–3; 4–5). Multivariable adjusted COX regression analyses of our study showed that Group 3 and Group 2 had a reduced risk of all-cause and cardio-cerebrovascular mortality (Group 3 vs 1, HR: 0.55, P < 0.001; HR: 0.4, P < 0.001; Group 2 vs 1, HR: 0.77, P = 0.017; HR: 0.58, P = 0.014) compared with Group 1. The same results were observed after excluding those who died in a relatively short time. Additionally, having more close friends, being married or living as married, and enough attending religious services were significantly related to a lower risk of mortality after adjustment. In brief, adequate social support is beneficial in reducing the risk of all-cause mortality and cardio-cerebrovascular mortality in middle-aged and older adults, especially in terms of attending religious services frequency, the number of close friends, and marital status.
- 27 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessThe protective effect of social support on all-cause and cardio-cerebrovascular mortality among middle-aged and older adults in the US
The relationship between social support and mortality, especially cardio-cerebrovascular mortality, still has some limitations in the assessment of social support, sample selection bias, and short follow-up time. We used the data from 2005 to 2008 National Health and Nutrition Examination Survey to examine this relationship. The study analyzed a total of 6776 participants, divided into Group 1, Group 2, and Group 3 according to the social support score (0–1; 2–3; 4–5). Multivariable adjusted COX regression analyses of our study showed that Group 3 and Group 2 had a reduced risk of all-cause and cardio-cerebrovascular mortality (Group 3 vs 1, HR: 0.55, P < 0.001; HR: 0.4, P < 0.001; Group 2 vs 1, HR: 0.77, P = 0.017; HR: 0.58, P = 0.014) compared with Group 1. The same results were observed after excluding those who died in a relatively short time. Additionally, having more close friends, being married or living as married, and enough attending religious services were significantly related to a lower risk of mortality after adjustment. In brief, adequate social support is beneficial in reducing the risk of all-cause mortality and cardio-cerebrovascular mortality in middle-aged and older adults, especially in terms of attending religious services frequency, the number of close friends, and marital status.
- 9 September 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 549, 117535
A serum LncRNA signature for predicting prognosis of triple-negative breast cancer
- 9 September 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 549, 117535
A serum LncRNA signature for predicting prognosis of triple-negative breast cancer
- Open Access
- 24 December 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 765818
Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious neurological conditions.Methods: Patients were prospectively recruited from March 2017 to September 2018 from a tertiary hospital to establish the development cohort for the internal test of the nomogram, while patients recruited from October 2018 to June 2019 from another tertiary hospital prospectively constituted the validation cohort for the external validation of the nomogram. A multivariate logistic regression analysis was performed in the development cohort using a backward stepwise method to determine the best-fit model for the nomogram. The nomogram was subsequently validated in an independent external validation cohort for discrimination and calibration. A decision-curve analysis was also performed to evaluate the net benefit of the insertion decision using the nomogram.Results: A total of 280 patients were enrolled in the development cohort, of whom 42 (15.0%) died, whereas 237 patients were enrolled in the validation cohort, of which 43 (18.1%) died. COP, neurological pathogenesis and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were predictors in the prediction nomogram. The derived cohort demonstrated good discriminative ability, and the area under the receiver operating characteristic curve (AUC) was 0.895 [95% confidence interval (CI), 0.840–0.951], showing good correction ability. The application of this nomogram to the validation cohort also provided good discrimination, with an AUC of 0.934 (95% CI, 0.892–0.976) and good calibration. The decision-curve analysis of this nomogram showed a better net benefit.Conclusions : A prediction nomogram incorporating COP, neurological pathogenesis and APACHE II score could be convenient in predicting mortality for critically ill neurological patients.
- 24 December 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 765818
Open AccessDevelopment and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious neurological conditions.Methods: Patients were prospectively recruited from March 2017 to September 2018 from a tertiary hospital to establish the development cohort for the internal test of the nomogram, while patients recruited from October 2018 to June 2019 from another tertiary hospital prospectively constituted the validation cohort for the external validation of the nomogram. A multivariate logistic regression analysis was performed in the development cohort using a backward stepwise method to determine the best-fit model for the nomogram. The nomogram was subsequently validated in an independent external validation cohort for discrimination and calibration. A decision-curve analysis was also performed to evaluate the net benefit of the insertion decision using the nomogram.Results: A total of 280 patients were enrolled in the development cohort, of whom 42 (15.0%) died, whereas 237 patients were enrolled in the validation cohort, of which 43 (18.1%) died. COP, neurological pathogenesis and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were predictors in the prediction nomogram. The derived cohort demonstrated good discriminative ability, and the area under the receiver operating characteristic curve (AUC) was 0.895 [95% confidence interval (CI), 0.840–0.951], showing good correction ability. The application of this nomogram to the validation cohort also provided good discrimination, with an AUC of 0.934 (95% CI, 0.892–0.976) and good calibration. The decision-curve analysis of this nomogram showed a better net benefit.Conclusions : A prediction nomogram incorporating COP, neurological pathogenesis and APACHE II score could be convenient in predicting mortality for critically ill neurological patients.
- 1 August 2020
- Published by Elsevier in Clinical Nutrition
- Vol. 39 (8) , 2406-2412
Simo decoction versus domperidone suspension for post-pyloric spiral nasoenteric tube placement: A multicenter, randomized, non-inferiority trial
- 1 August 2020
- Published by Elsevier in Clinical Nutrition
- Vol. 39 (8) , 2406-2412
Simo decoction versus domperidone suspension for post-pyloric spiral nasoenteric tube placement: A multicenter, randomized, non-inferiority trial
- Open Access
- 1 December 2019
- Published by Elsevier in Clinical Nutrition
- Vol. 38 (6) , 2799-2805
Development and validation of a nomogram for predicting self-propelled postpyloric placement of spiral nasoenteric tube in the critically ill: Mixed retrospective and prospective cohort study
- 1 December 2019
- Published by Elsevier in Clinical Nutrition
- Vol. 38 (6) , 2799-2805
Open AccessDevelopment and validation of a nomogram for predicting self-propelled postpyloric placement of spiral nasoenteric tube in the critically ill: Mixed retrospective and prospective cohort study
- Open Access
- 7 March 2017
- Published by Springer Nature in Critical Care
- Vol. 21 (1) , 1-11
Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study
Although serum cystatin C (sCysC), urinary N-acetyl-β-d-glucosaminidase (uNAG), and urinary albumin/creatinine ratio (uACR) are clinically available, their optimal combination for acute kidney injury (AKI) detection and prognosis prediction remains unclear. We aimed to assess the discriminative abilities of these biomarkers and their possible combinations for AKI detection and intensive care unit (ICU) mortality prediction in critically ill adults. A multicenter, prospective observational study was conducted in mixed medical-surgical ICUs at three tertiary care hospitals. One thousand eighty-four adult critically ill patients admitted to the ICUs were studied. We assessed the use of individual biomarkers (sCysC, uNAG, and uACR) measured at ICU admission and their combinations with regard to AKI detection and prognosis prediction. AUC-ROCs for sCysC, uNAG, and uACR were calculated for total AKI (0.738, 0.650, and 0.683, respectively), severe AKI (0.839, 0.706, and 0.771, respectively), and ICU mortality (0.727, 0.793, and 0.777, respectively). The panel of sCysC plus uNAG detected total and severe AKI with significantly higher accuracy than either individual biomarkers or the other two panels (uNAG plus uACR or sCysC plus uACR). For detecting total AKI, severe AKI, and ICU mortality at ICU admission, this panel yielded AUC-ROCs of 0.756, 0.863, and 0.811, respectively; positive predictive values of 0.71, 0.31, and 0.17, respectively; and negative predictive values of 0.81, 0.97, and 0.98, respectively. Moreover, this panel significantly contributed to the accuracy of the clinical models for AKI detection and ICU mortality prediction, as measured by the AUC-ROC, continuous net reclassification index, and incremental discrimination improvement index. The comparable performance of this panel was further confirmed with bootstrap internal validation. The combination of a functional marker (sCysC) and a tubular damage marker (uNAG) revealed significantly superior discriminative performance for AKI detection and yielded additional prognostic information on ICU mortality.
- 7 March 2017
- Published by Springer Nature in Critical Care
- Vol. 21 (1) , 1-11
Open AccessEvaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study
Although serum cystatin C (sCysC), urinary N-acetyl-β-d-glucosaminidase (uNAG), and urinary albumin/creatinine ratio (uACR) are clinically available, their optimal combination for acute kidney injury (AKI) detection and prognosis prediction remains unclear. We aimed to assess the discriminative abilities of these biomarkers and their possible combinations for AKI detection and intensive care unit (ICU) mortality prediction in critically ill adults. A multicenter, prospective observational study was conducted in mixed medical-surgical ICUs at three tertiary care hospitals. One thousand eighty-four adult critically ill patients admitted to the ICUs were studied. We assessed the use of individual biomarkers (sCysC, uNAG, and uACR) measured at ICU admission and their combinations with regard to AKI detection and prognosis prediction. AUC-ROCs for sCysC, uNAG, and uACR were calculated for total AKI (0.738, 0.650, and 0.683, respectively), severe AKI (0.839, 0.706, and 0.771, respectively), and ICU mortality (0.727, 0.793, and 0.777, respectively). The panel of sCysC plus uNAG detected total and severe AKI with significantly higher accuracy than either individual biomarkers or the other two panels (uNAG plus uACR or sCysC plus uACR). For detecting total AKI, severe AKI, and ICU mortality at ICU admission, this panel yielded AUC-ROCs of 0.756, 0.863, and 0.811, respectively; positive predictive values of 0.71, 0.31, and 0.17, respectively; and negative predictive values of 0.81, 0.97, and 0.98, respectively. Moreover, this panel significantly contributed to the accuracy of the clinical models for AKI detection and ICU mortality prediction, as measured by the AUC-ROC, continuous net reclassification index, and incremental discrimination improvement index. The comparable performance of this panel was further confirmed with bootstrap internal validation. The combination of a functional marker (sCysC) and a tubular damage marker (uNAG) revealed significantly superior discriminative performance for AKI detection and yielded additional prognostic information on ICU mortality.